Literature DB >> 30405185

Vaccines to treat opioid use disorders and to reduce opioid overdoses.

Carly Baehr1,2, Marco Pravetoni3,4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30405185      PMCID： PMC6235930          DOI： 10.1038/s41386-018-0197-3

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN： 0893-133X            Impact factor:   7.853


× No keyword cloud information.
  10 in total

1.  Vaccine blunts fentanyl potency in male rhesus monkeys.

Authors:  Rebekah D Tenney; Steven Blake; Paul T Bremer; Bin Zhou; Candy S Hwang; Justin L Poklis; Kim D Janda; Matthew L Banks
Journal:  Neuropharmacology       Date:  2019-07-29       Impact factor: 5.250

2.  Effectiveness and selectivity of a heroin conjugate vaccine to attenuate heroin, 6-acetylmorphine, and morphine antinociception in rats: Comparison with naltrexone.

Authors:  Kathryn L Schwienteck; Steven Blake; Paul T Bremer; Justin L Poklis; E Andrew Townsend; S Stevens Negus; Matthew L Banks
Journal:  Drug Alcohol Depend       Date:  2019-08-24       Impact factor: 4.492

Review 3.  Unique Pharmacology, Brain Dysfunction, and Therapeutic Advancements for Fentanyl Misuse and Abuse.

Authors:  Ying Han; Lu Cao; Kai Yuan; Jie Shi; Wei Yan; Lin Lu
Journal:  Neurosci Bull       Date:  2022-05-15       Impact factor: 5.271

4.  Pharmacy stakeholder reports on ethical and logistical considerations in anti-opioid vaccine development.

Authors:  Vincent Wartenweiler; Grace Chung; Amy Stewart; Cody Wenthur
Journal:  BMC Med Ethics       Date:  2021-03-25       Impact factor: 2.652

5.  Design, Synthesis, and In Vivo Evaluation of C1-Linked 4,5-Epoxymorphinan Haptens for Heroin Vaccines.

Authors:  Agnieszka Sulima; Fuying Li; Jeffrey Brian Morgan; Phong Truong; Joshua F G Antoline; Therese Oertel; Rodell C Barrientos; Oscar B Torres; Zoltan Beck; Gregory H Imler; Jeffrey R Deschamps; Gary R Matyas; Arthur E Jacobson; Kenner C Rice
Journal:  Molecules       Date:  2022-02-25       Impact factor: 4.927

6.  A Rapid Method for Direct Quantification of Antibody Binding-Site Concentration in Serum.

Authors:  Erwin G Abucayon; Connor Whalen; Oscar B Torres; Alexander J Duval; Agnieszka Sulima; Joshua F G Antoline; Therese Oertel; Rodell C Barrientos; Arthur E Jacobson; Kenner C Rice; Gary R Matyas
Journal:  ACS Omega       Date:  2022-07-19

7.  Synthesis and immunological effects of C14-linked 4,5-epoxymorphinan analogues as novel heroin vaccine haptens.

Authors:  Eugene S Gutman; Thomas C Irvin; J Brian Morgan; Rodell C Barrientos; Oscar B Torres; Zoltan Beck; Gary R Matyas; Arthur E Jacobson; Kenner C Rice
Journal:  RSC Chem Biol       Date:  2021-04-19

Review 8.  Preclinical Evaluation of Vaccines to Treat Opioid Use Disorders: How Close are We to a Clinically Viable Therapeutic?

Authors:  E Andrew Townsend; Matthew L Banks
Journal:  CNS Drugs       Date:  2020-05       Impact factor: 5.749

9.  Novel Vaccine That Blunts Fentanyl Effects and Sequesters Ultrapotent Fentanyl Analogues.

Authors:  Rodell C Barrientos; Eric W Bow; Connor Whalen; Oscar B Torres; Agnieszka Sulima; Zoltan Beck; Arthur E Jacobson; Kenner C Rice; Gary R Matyas
Journal:  Mol Pharm       Date:  2020-08-13       Impact factor: 4.939

10.  Bivalent Conjugate Vaccine Induces Dual Immunogenic Response That Attenuates Heroin and Fentanyl Effects in Mice.

Authors:  Rodell C Barrientos; Connor Whalen; Oscar B Torres; Agnieszka Sulima; Eric W Bow; Essie Komla; Zoltan Beck; Arthur E Jacobson; Kenner C Rice; Gary R Matyas
Journal:  Bioconjug Chem       Date:  2021-06-02       Impact factor: 4.774
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.